151 related articles for article (PubMed ID: 12651658)
21. A Case of Anaphylaxis to Patent Blue in a Patient with Sentinel Lymph Node Excision.
Aurich S; Seitz AT; Tomm J; Simon JC; Treudler R
Iran J Allergy Asthma Immunol; 2016 Dec; 15(6):547-550. PubMed ID: 28129687
[TBL] [Abstract][Full Text] [Related]
22. Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol.
Raut CP; Hunt KK; Akins JS; Daley MD; Ross MI; Singletary SE; Marshall GD; Meric-Bernstam F; Babiera G; Feig BW; Ames FC; Kuerer HM
Cancer; 2005 Aug; 104(4):692-9. PubMed ID: 15981283
[TBL] [Abstract][Full Text] [Related]
23. Anaphylaxis to isosulfan blue and cross-reactivity to patent blue V: case report and review of the nomenclature of vital blue dyes.
Scherer K; Studer W; Figueiredo V; Bircher AJ
Ann Allergy Asthma Immunol; 2006 Mar; 96(3):497-500. PubMed ID: 16597088
[TBL] [Abstract][Full Text] [Related]
24. Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis.
Raut CP; Daley MD; Hunt KK; Akins J; Ross MI; Singletary SE; Marshall GD; Meric-Bernstam F; Babiera G; Feig BW; Ames FC; Kuerer HM
J Clin Oncol; 2004 Feb; 22(3):567-8. PubMed ID: 14752082
[No Abstract] [Full Text] [Related]
25. Anaphylactic reaction to isosulfan blue used for sentinel node biopsy: case report and literature review.
Efron P; Knudsen E; Hirshorn S; Copeland EM
Breast J; 2002; 8(6):396-9. PubMed ID: 12390368
[TBL] [Abstract][Full Text] [Related]
26. Anaphylaxis to patent blue dye--the benefit and the risk.
Kollias J; Russell WJ
Anaesth Intensive Care; 2011 Jul; 39(4):758-60; author reply 760. PubMed ID: 21826816
[No Abstract] [Full Text] [Related]
27. Adverse reaction; patent blue turning patient blue.
Joshi M; Hart M; Ahmed F; McPherson S
BMJ Case Rep; 2012 Nov; 2012():. PubMed ID: 23203181
[TBL] [Abstract][Full Text] [Related]
28. [Patent blue V : inert dye or potent allergen].
Rogler V; Röhm C; Reutershan J
Anaesthesist; 2010 May; 59(5):423-6. PubMed ID: 20224949
[TBL] [Abstract][Full Text] [Related]
29. Allergic reactions to patent blue dye.
Mansouri R; Chicken DW; Keshtgar MR
Surg Oncol; 2006 Jul; 15(1):58. PubMed ID: 16893646
[No Abstract] [Full Text] [Related]
30. Allergy to Blue Dye.
Martín-Lázaro J; Núñez-Orjales R; Battikhi-Precedo N; López-Freire S; Carballada-González F
J Investig Allergol Clin Immunol; 2016; 26(6):381-383. PubMed ID: 27996948
[No Abstract] [Full Text] [Related]
31. Kounis syndrome after patent blue dye injection for sentinel lymph node biopsy.
Frountzas M; Karathanasis P; Vrakopoulou GZ; Theodoropoulos C; Zografos CG; Schizas D; Zografos GC; Michalopoulos NV
Breast Cancer; 2020 Nov; 27(6):1191-1197. PubMed ID: 32601801
[TBL] [Abstract][Full Text] [Related]
32. Blue dye of choice for lymphatic mapping.
Vargas HI
J Clin Oncol; 2005 May; 23(15):3648; author reply 3648-9. PubMed ID: 15908691
[No Abstract] [Full Text] [Related]
33. Anaphylaxis after peritumoral injection of sulphan blue 1% for identification of the sentinel node in lymphatic mapping of the breast.
Giménez J; Botella-Estrada R; Hernández D; Carbonell M; Martínez MA; Guillén C; Vázquez C
Eur J Surg; 2001 Dec; 167(12):921-3. PubMed ID: 11841084
[No Abstract] [Full Text] [Related]
34. Allergic reactions to isosulfan blue during sentinel node biopsy--a common event.
Cimmino VM; Brown AC; Szocik JF; Pass HA; Moline S; De SK; Domino EF
Surgery; 2001 Sep; 130(3):439-42. PubMed ID: 11562667
[TBL] [Abstract][Full Text] [Related]
35. [Hypotension and oxygen saturation fall in a woman during sentinel lymph node biopsy].
Johnsen L; Ilsaas C; Salthe J; Lende TH; Bjerkeset O; Søiland H
Tidsskr Nor Laegeforen; 2011 May; 131(8):840-1. PubMed ID: 21556090
[No Abstract] [Full Text] [Related]
36. Adverse drug reactions during lymphatic mapping and sentinel lymph node biopsy for solid neoplasms.
Amr D; Broderick-Villa G; Haigh PI; Guenther JM; DiFronzo LA
Am Surg; 2005 Sep; 71(9):720-4. PubMed ID: 16468505
[TBL] [Abstract][Full Text] [Related]
37. Anaphylaxis and patent Blue V.
Pyke C
Anaesth Intensive Care; 2011 Jul; 39(4):758; author reply 760. PubMed ID: 21823395
[No Abstract] [Full Text] [Related]
38. [Dangerous blue?].
Varhaug JE
Tidsskr Nor Laegeforen; 2011 May; 131(8):842. PubMed ID: 21556091
[No Abstract] [Full Text] [Related]
39. Adverse reactions to patent blue V dye - The NEW START and ALMANAC experience.
Barthelmes L; Goyal A; Newcombe RG; McNeill F; Mansel RE;
Eur J Surg Oncol; 2010 Apr; 36(4):399-403. PubMed ID: 19939618
[TBL] [Abstract][Full Text] [Related]
40. Anaphylaxis during breast cancer lymphatic mapping.
Kuerer HM; Wayne JD; Ross MI
Surgery; 2001 Jan; 129(1):119-20. PubMed ID: 11150045
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
